Delivery Order SPE2DR25D1106-SPE2DR26FJB4S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL units at a firm fixed price of $4,058.09. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The work is...
- The Defense Logistics Agency awarded a delivery order valued at $1,868.26 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units). This is a firm fixed price delivery order with an ultimate completion date of November 17, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml quantities, with a firm fixed price ceiling value of $1,908.72. The contract, which is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $1,154.95 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml) pharmaceutical product, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,136.89 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 mL in 200 mL units). This non-set-aside, firm fixed-price delivery order was competitively awarded on December 5, 2025, with an ultimate completion date of December 8, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ropivacaine 0.2% in 400 mg/200 mL vials with a ceiling value of $1,431.54. This is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competitive set-aside contract. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $5,061.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units). This is a non-set-aside competitive award with an ultimate completion date of December 9, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively modest procurement action within the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL, 200 mL units) with a ceiling value of $5,149.90. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units) at a ceiling value of $1,431.54. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is performed out of the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,646.08 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml), a local anesthetic pharmaceutical product. The contract, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB4SDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,162.46 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml, 200 ml units) with a completion date of December 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a broad portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The SPE2DX contract enables the company to deliver specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Ropivacaine, a local anesthetic commonly used in medical procedures, represents one of numerous pharmaceutical deliveries the company fulfills through its established federal contract relationships with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/30/25 |